Astorg to Acquire Thermo Fisher Scientific’s Global Microbiology Business
April 28, 2026
Astorg has signed a definitive agreement to acquire Thermo Fisher Scientific’s global microbiology business in a carve-out transaction. The unit will operate as an independent, privately owned platform backed by Astorg, focused on antimicrobial susceptibility testing and microbiology diagnostics. The deal is expected to close in the second half of 2026 (and is later reported as completed in 2026).
- Buyers
- Astorg
- Targets
- Thermo Fisher Scientific (Microbiology business unit)
- Sellers
- Thermo Fisher Scientific
- Platforms
- Astorg VIII
- Industry
- Healthcare Services
- Location
- United States
- Transaction Type
- Buyout
Explore More
Build a buyer list for your deal
Find active buyers from recent acquisition patterns and move straight into outreach.